Dubroff: Leadership on tech, housing needed to fix Santa Barbara’s woes
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
UCSB researchers get $9 million to develop new brain imaging
UC Santa Barbara researchers received $9 million to further their efforts to get a better view of the human brain. The National Science Foundation awarded the funding to the Next Generation Multiphoton Neuroimaging Consortium project, or NEMONIC, which includes UCSB researchers John Bowers, Michael Goard and Luke Theogarajan among its team of neuroscientists, electrical engineers, Read More →
CalAmp reports revenue decline but net income up
Information technology company CalAmp reported on Sept. 28 a slight drop in revenue for its second quarter but a dramatic increase in net income, bringing in $12.2 million, or 34 cents per share. The company, which has operations in Oxnard, brought in $89.8 million during the quarter, down slightly from $90.5 million in the second Read More →
Museum of Ventura County replaces board with 11 new members
Updated at 10:20 a.m. Sept. 29: The Museum of Ventura County has replaced its board of directors and elected 11 new board members, it announced in a news release Sept. 28. The museum has faced financial woes and possible closure in the past few years. It streamlined its budget to $1.1 million as of May Read More →
Amgen settles with AbbVie over Humira biosimilar
Thousand Oaks biopharmaceutical giant Amgen announced Sept. 28 that it had reached a settlement with Chicago-based competitor AbbVie, which had sued to block Amgen’s Humira biosimilar Amjevita. The rheumatoid arthritis and inflammation treatment received U.S. Food and Drug Administration approval in September of 2016, but sales were blocked when AbbVie filed a patent infringement claim Read More →
Amgen agrees to develop biosimilars for Chinese market
Increasing its global footprint in the biosimilars market, Amgen announced Sept. 26 that it had formed an exclusive co-development agreement with Chinese drug manufacturer Simcere Pharmaceutical Group. The agreement aims to bring four oncology and inflammation biosimilars in Amgen’s portfolio to commercialization in China. The Thousand Oaks-based biotechnology company will produce and submit approval applications Read More →
Fess Parker to be renamed Hilton Santa Barbara Beachfront Resort
The Fess Parker — A Doubletree by Hilton Resort will be renamed the Hilton Santa Barbara Beachfront Resort after a two-part renovation beginning in October. The first phase of renovations will update guest rooms, the lobby, the Roundhouse Restaurant and Java Del Mar, and the second phase will include meeting spaces such as the site’s Read More →
